uric acid has been researched along with tacrolimus in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Fung, J; Iqbal, M; Jain, A; Starzl, TE; Todo, S; Van Thiel, DH | 1 |
| Alessiani, M; Day, R; Demetris, AJ; Fung, JJ; Gordon, R; Jain, A; Starzl, TE; Takaya, S; Todo, S; Tzakis, A | 1 |
| Abu-Elmagd, K; Fung, JJ; Irish, WD; Nikolaidis, NL; Rilo, HR; Starzl, TE; Thomson, AW; Van Thiel, DH | 1 |
| Endo, T; Fukao, K; Ishibashi, M; Morozumi, K; Ochiai, T; Ohshima, S; Takahara, S; Takahashi, K; Uchida, K; Yokoyama, I | 1 |
| Arlt, M; Brückner, D; Buchholz, B; Hohage, H; Spieker, C; Zidek, W | 1 |
| Fernando, ON; Sweny, P; Varghese, Z | 1 |
| Dittmer, I; Faire, B; Pilmore, HL | 1 |
| Amenábar, JJ; Gaínza, FI; Gómez-Ullate, P; Lampreabe, I; Orbe, J; Urbizu, JM; Virto, J; Zárraga, S | 1 |
| Goldfarb, DS; Hwang, MT | 1 |
| Gerhardt, U; Heck, M; Hohage, H; Suwelack, BM; Welling, U; Zeh, M | 1 |
| Akcay, A; Arat, Z; Haberal, M; Huddam, B; Kanbay, M; Ozdemir, FN; Usluogullari, CA | 1 |
| Arikan, C; Aydogdu, S; Kilic, M; Tumgor, G | 1 |
| Ayoub, AA; Gibelli, NE; Maksoud, JG; Maksoud-Filho, JG; Pinho-Apezzato, ML; Santos, MM; Silva, MM; Tannuri, U; Velhote, MC | 1 |
| Butani, L; Peterson, JM | 1 |
| Akiyama, T; Amada, N; Takahara, S; Takahashi, K; Tanabe, K; Toma, H; Uchida, K | 1 |
| Abbas, M; Dablouk, N; El-Magzoub, AR; Elamin, S; Mahmoud, F | 1 |
| Chan, KM; Cheng, CH; Chou, HS; Lee, CF; Lee, WC; Soong, RS; Thorat, A; Wu, TH; Wu, TJ | 1 |
| Ali, FEM; Azouz, AA; Hersi, F; Hussein Elkelawy, AMM; Omar, HA | 1 |
| Hami, M; Mehrad-Majd, H; Miri, M; Salari, M; Yaghoubi, MA | 1 |
6 trial(s) available for uric acid and tacrolimus
| Article | Year |
|---|---|
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
Topics: Amylases; Cholesterol; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney; Kidney Transplantation; Potassium; Prednisolone; Survival Rate; Tacrolimus; Time Factors; Triglycerides; Uric Acid | 1995 |
Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.
Topics: Cholesterol; Creatinine; Cyclosporine; Follow-Up Studies; Humans; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Tacrolimus; Time Factors; Uric Acid | 1998 |
Conversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Creatinine; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Risk Factors; Tacrolimus; Uric Acid | 2005 |
Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Topics: Adult; Cyclosporine; Female; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Tacrolimus; Uric Acid | 2005 |
Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
Topics: Adult; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Tacrolimus; Uric Acid | 2013 |
Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemistry, Pharmaceutical; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kidney Function Tests; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Patient Satisfaction; Tacrolimus; Uric Acid | 2014 |
13 other study(ies) available for uric acid and tacrolimus
| Article | Year |
|---|---|
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Topics: Amylases; Anti-Bacterial Agents; Blood Glucose; Cholesterol; Cyclosporins; Digestive System; Humans; Immunosuppressive Agents; Liver Transplantation; Tacrolimus; Uric Acid | 1990 |
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Cause of Death; Cholesterol; Creatine; Cyclosporins; gamma-Glutamyltransferase; Graft Survival; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Jaundice; Kidney; Liver Transplantation; Prednisone; Survival Analysis; Tacrolimus; Uric Acid | 1991 |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases.
Topics: Adult; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Creatinine; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Psoriasis; Tacrolimus; Uric Acid | 1991 |
Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood Urea Nitrogen; Creatinine; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Tacrolimus; Uric Acid | 1996 |
Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature.
Topics: Adult; Cyclosporine; Female; Gout; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Uric Acid | 2001 |
Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Safety; Tacrolimus; Time Factors; Uric Acid | 2003 |
Uric acid stones following hepatic transplantation.
Topics: Calcineurin Inhibitors; Cyclosporine; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Kidney Calculi; Lithiasis; Liver Transplantation; Male; Middle Aged; Tacrolimus; Uric Acid | 2004 |
Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Topics: Adolescent; Chi-Square Distribution; Child; Child, Preschool; Creatinine; Cyclosporine; Female; Humans; Hyperuricemia; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Postoperative Complications; Tacrolimus; Treatment Outcome; Uric Acid | 2006 |
Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center.
Topics: Adolescent; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Failure; Liver Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Uric Acid; Vaccination | 2007 |
Determinants of urinary calcium and uric acid excretion in children after renal transplantation.
Topics: Adolescent; Adult; Biomarkers; Calcium; Child; Child, Preschool; Female; Hematuria; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrolithiasis; Postoperative Complications; Tacrolimus; Uric Acid | 2007 |
Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
Topics: Adolescent; Adult; Antifungal Agents; Biomarkers; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Ketoconazole; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Treatment Outcome; Uric Acid; Young Adult | 2014 |
Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Calcineurin Inhibitors; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Glutamate-Cysteine Ligase; Kidney Diseases; Male; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Superoxide Dismutase; Tacrolimus; Uric Acid; Xanthenes | 2022 |
Association of Metabolic Syndrome and Hyperuricemia in the Recipients of Kidney Transplants: A Single-Center Study.
Topics: Cross-Sectional Studies; Humans; Hyperuricemia; Kidney Transplantation; Metabolic Syndrome; Tacrolimus; Uric Acid | 2023 |